Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Use of Topotecan in Patients With Refractory Acute Leukemia

This study has been completed.
Immunex Corporation
SmithKline Beecham
Information provided by (Responsible Party):
VA Office of Research and Development Identifier:
First received: December 30, 2004
Last updated: September 24, 2013
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2001
  Primary Completion Date: January 2001 (Final data collection date for primary outcome measure)